262 related articles for article (PubMed ID: 24371138)
21. Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.
Guan P; Sun ZM; Wang N; Zhou J; Luo LF; Zhao YS; Ji ES
Life Sci; 2019 Sep; 233():116748. PubMed ID: 31412263
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
[TBL] [Abstract][Full Text] [Related]
23. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
Aasum E; Hafstad AD; Severson DL; Larsen TS
Diabetes; 2003 Feb; 52(2):434-41. PubMed ID: 12540618
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy.
Pang J; Peng H; Wang S; Xu X; Xu F; Wang Q; Chen Y; Barton LA; Chen Y; Zhang Y; Ren J
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1627-1641. PubMed ID: 30946956
[TBL] [Abstract][Full Text] [Related]
26. Modulation of oxidative-nitrosative stress and inflammatory response by rapamycin in target and distant organs in rats exposed to hindlimb ischemia-reperfusion: the role of mammalian target of rapamycin.
Kocak Z; Temiz-Resitoglu M; Guden DS; Vezir O; Sucu N; Balcı S; Tamer-Gumus L; Tunctan B; Malik KU; Sahan-Firat S
Can J Physiol Pharmacol; 2019 Dec; 97(12):1193-1203. PubMed ID: 31505123
[TBL] [Abstract][Full Text] [Related]
27. Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress.
Prasad V; Lorenz JN; Miller ML; Vairamani K; Nieman ML; Wang Y; Shull GE
J Mol Cell Cardiol; 2013 Dec; 65():33-42. PubMed ID: 24080184
[TBL] [Abstract][Full Text] [Related]
28. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
29. Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation.
Cattin ME; Wang J; Weldrick JJ; Roeske CL; Mak E; Thorn SL; DaSilva JN; Wang Y; Lusis AJ; Burgon PG
J Biol Chem; 2015 Oct; 290(44):26699-714. PubMed ID: 26359501
[TBL] [Abstract][Full Text] [Related]
30. Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.
Aoyagi T; Higa JK; Aoyagi H; Yorichika N; Shimada BK; Matsui T
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1530-9. PubMed ID: 25888508
[TBL] [Abstract][Full Text] [Related]
31. Short-term exercise worsens cardiac oxidative stress and fibrosis in 8-month-old db/db mice by depleting cardiac glutathione.
Laher I; Beam J; Botta A; Barendregt R; Sulistyoningrum D; Devlin A; Rheault M; Ghosh S
Free Radic Res; 2013 Jan; 47(1):44-54. PubMed ID: 23039789
[TBL] [Abstract][Full Text] [Related]
32. Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.
Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
Endocr Relat Cancer; 2010 Dec; 17(4):941-51. PubMed ID: 20801951
[TBL] [Abstract][Full Text] [Related]
33. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
34. Chronic rapamycin treatment exacerbates metabolism and does not down-regulate mTORC2/Akt signaling in diabetic mice induced by high-fat diet and streptozotocin.
Wang Y; He Z; Li X; Chen W; Lu J; Chen X; Cao L
Pharmazie; 2015 Sep; 70(9):604-9. PubMed ID: 26492646
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
36. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
37. Choline Inhibits Ischemia-Reperfusion-Induced Cardiomyocyte Autophagy in Rat Myocardium by Activating Akt/mTOR Signaling.
Hang P; Zhao J; Su Z; Sun H; Chen T; Zhao L; Du Z
Cell Physiol Biochem; 2018; 45(5):2136-2144. PubMed ID: 29533930
[TBL] [Abstract][Full Text] [Related]
38. Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways.
Lesniewski LA; Seals DR; Walker AE; Henson GD; Blimline MW; Trott DW; Bosshardt GC; LaRocca TJ; Lawson BR; Zigler MC; Donato AJ
Aging Cell; 2017 Feb; 16(1):17-26. PubMed ID: 27660040
[TBL] [Abstract][Full Text] [Related]
39. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
40. Amino acid supplementation counteracts metabolic and functional damage in the diabetic rat heart.
Pellegrino MA; Patrini C; Pasini E; Brocca L; Flati V; Corsetti G; D'Antona G
Am J Cardiol; 2008 Jun; 101(11A):49E-56E. PubMed ID: 18514627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
